AAAAAA

   
Results: 1-10 |
Results: 10
THE CZECH-REPUBLIC AND SLOVAK-REPUBLIC - NATION VERSUS STATE - NATIONS OF THE MODERN-WORLD - LEFF,CS
Authors: SATTERWHITE JH
Citation: Jh. Satterwhite, THE CZECH-REPUBLIC AND SLOVAK-REPUBLIC - NATION VERSUS STATE - NATIONS OF THE MODERN-WORLD - LEFF,CS, Europe-Asia studies, 49(8), 1997, pp. 1549-1551
PHARMACOKINETIC PROFILE OF LY333334, BIOSYNTHETIC HUMAN PARATHYROID-HORMONE (HPTH)(1-34), AND SERUM BIOCHEMISTRY AFTER ANABOLIC OR CATABOLIC INJECTION PROTOCOLS
Authors: FROLIK CA BLACK EC CAIN RL HOCK JM OSBORNE JJ SATTERWHITE JH
Citation: Ca. Frolik et al., PHARMACOKINETIC PROFILE OF LY333334, BIOSYNTHETIC HUMAN PARATHYROID-HORMONE (HPTH)(1-34), AND SERUM BIOCHEMISTRY AFTER ANABOLIC OR CATABOLIC INJECTION PROTOCOLS, Journal of bone and mineral research, 12, 1997, pp. 371-371
EFFECTS OF AGE ON THE PHARMACODYNAMICS OF NAPROXEN IN THE RAT
Authors: SATTERWHITE JH BOUDINOT FD
Citation: Jh. Satterwhite et Fd. Boudinot, EFFECTS OF AGE ON THE PHARMACODYNAMICS OF NAPROXEN IN THE RAT, Experimental gerontology, 30(5), 1995, pp. 505-515
THE SAFETY AND TOLERANCE OF XANOMELINE TARTRATE IN PATIENTS WITH ALZHEIMERS-DISEASE
Authors: SRAMEK JJ HURLEY DJ WARDLE TS SATTERWHITE JH HOURANI J DIES F CUTLER NR
Citation: Jj. Sramek et al., THE SAFETY AND TOLERANCE OF XANOMELINE TARTRATE IN PATIENTS WITH ALZHEIMERS-DISEASE, Journal of clinical pharmacology, 35(8), 1995, pp. 800-806
MASARYK,T.G. - AGAINST THE CURRENT, 1882-1914 - SKILLING,HG
Authors: SATTERWHITE JH
Citation: Jh. Satterwhite, MASARYK,T.G. - AGAINST THE CURRENT, 1882-1914 - SKILLING,HG, Slavic review, 54(4), 1995, pp. 1124-1125
THE CHURCH AND THE LEFT - MICHNIK,A
Authors: SATTERWHITE JH
Citation: Jh. Satterwhite, THE CHURCH AND THE LEFT - MICHNIK,A, Slavic review, 54(3), 1995, pp. 793-794
SAFETY, TOLERANCE, AND PHARMACOKINETICS OF XANOMELINE TARTRATE, A NOVEL MUSCARINIC M1 AGONIST IN HEALTHY ELDERLY SUBJECTS
Authors: SATTERWHITE JH LUCAS RA HEATON J CARTER GV
Citation: Jh. Satterwhite et al., SAFETY, TOLERANCE, AND PHARMACOKINETICS OF XANOMELINE TARTRATE, A NOVEL MUSCARINIC M1 AGONIST IN HEALTHY ELDERLY SUBJECTS, Neurobiology of aging, 15, 1994, pp. 190000104-190000104
SINGLE AND MULTIPLE-DOSE SAFETY, PHARMACODYNAMICS AND PHARMACOKINETICS OF XANOMELINE, A NOVEL MUSCARINIC M1 AGONIST IN HEALTHY MALE-SUBJECTS
Authors: BODICK NC SATTERWHITE JH LUCAS RA HEATON J CARTER GV
Citation: Nc. Bodick et al., SINGLE AND MULTIPLE-DOSE SAFETY, PHARMACODYNAMICS AND PHARMACOKINETICS OF XANOMELINE, A NOVEL MUSCARINIC M1 AGONIST IN HEALTHY MALE-SUBJECTS, Neurobiology of aging, 15, 1994, pp. 190000104-190000105
ABSORPTION, DISTRIBUTION, METABOLISM, AND ELIMINATION OF RADIOLABELEDXANOMELINE IN HEALTHY MALE-SUBJECTS
Authors: DELONG AF BONATE PL GILLESPIE T HENRY DP SATTERWHITE JH
Citation: Af. Delong et al., ABSORPTION, DISTRIBUTION, METABOLISM, AND ELIMINATION OF RADIOLABELEDXANOMELINE IN HEALTHY MALE-SUBJECTS, Neurobiology of aging, 15, 1994, pp. 190000105-190000105
RISK SOCIETY - TOWARDS A NEW MODERNITY - BECK,U
Authors: SATTERWHITE JH
Citation: Jh. Satterwhite, RISK SOCIETY - TOWARDS A NEW MODERNITY - BECK,U, Social science quarterly, 75(1), 1994, pp. 236-237
Risultati: 1-10 |